Not medical advice. This site is general information only. In an emergency call your local emergency number. For advice about your own health, speak to a doctor, pharmacist or other qualified health professional.
NSABP B-04
About the Trial
Bernard Fisher randomized 1,665 breast cancer patients to radical mastectomy, total mastectomy with radiation, or total mastectomy without axillary dissection, with nodes removed only if they later became positive. After 25 years of follow up there were no survival differences among the groups. The Halstedian paradigm, that breast cancer spreads in orderly fashion requiring ever wider local excision, was destroyed. Breast conserving approaches became possible. B-04, with B-06, which added lumpectomy, rewired surgical oncology toward less invasive surgery and toward systemic therapy as the driver of survival. It stands among the most consequential surgical trials ever conducted.
Related Trials
DCCT
The Diabetes Control and Complications Trial randomized 1,441 type 1 diabetes patients to intensive versus conventional insulin th...
UKPDS
The UK Prospective Diabetes Study followed over 5,000 newly diagnosed type 2 diabetes patients for a median of 10 years. Intensive...
ACCORD
The Action to Control Cardiovascular Risk in Diabetes trial tested intensive glucose control targeting HbA1c under 6.0 percent in ...
ADVANCE
ADVANCE randomized 11,140 type 2 diabetes patients to intensive gliclazide based glucose control or standard therapy. Intensive co...